TGM3
TGM3 (Protein-glutamine gamma-glutamyltransferase E) is an enzyme. In the public catalogues the evidence so far is association rather than a proven role. Tied to Skin cancer and Basal cell carcinoma.
Overview
Catalyses the calcium-dependent formation of isopeptide cross-links between glutamine and lysine residues in various proteins, as well as the conjugation of polyamines to proteins. Involved in the formation of the cornified envelope (CE), a specialised component consisting of covalent cross-links of proteins beneath the plasma membrane of terminally differentiated keratinocytes. Catalyses small proline-rich proteins (SPRR1 and SPRR2) and LOR cross-linking to form small interchain oligomers, which are further cross-linked by TGM1 onto the growing CE scaffold.
Open Targets scores its association with cancer at 0.57 (direct and indirect evidence; datatypes literature 0.91, animal model 0.70, genetic association 0.70).
- Target · the protein and the cell it sits on
- Drug · antibody, small molecule, cell or radioligand
- Effect · signal, damage or kill
In plain words · TGM3 (Protein-glutamine gamma-glutamyltransferase E) is an enzyme. In the public catalogues the evidence so far is association rather than a proven role. Tied to Skin cancer and Basal cell carcinoma.
- 1 · What it is
TGM3 (Protein-glutamine gamma-glutamyltransferase E) is an enzyme. In the public catalogues the evidence so far is association rather than a proven role. Tied to Skin cancer and Basal cell carcinoma.
- 2 · What goes wrong in cancer
Catalyses the calcium-dependent formation of isopeptide cross-links between glutamine and lysine residues in various proteins, as well as the conjugation of polyamines to proteins.
- 3 · How drugs use it
No product in this corpus aims at TGM3 yet. Inhibitors are shaped to fit the enzyme's active site so the reaction the cancer relies on stops.
External identifiers
Sources: HGNC HGNC:11779 (approved symbol, name, aliases, locus and cross-references (hgnc_complete_set.txt)); UniProt Q08188 (protein name, function text, keywords and locations (REST API)); Open Targets ENSG00000125780 (association with cancer (MONDO_0004992) 0.57; per-cancer scores at or above 0.5: skin cancer 0.54, basal cell carcinoma 0.53 (GraphQL API, CC0))
Biology
Catalyses the calcium-dependent formation of isopeptide cross-links between glutamine and lysine residues in various proteins, as well as the conjugation of polyamines to proteins. Involved in the formation of the cornified envelope (CE), a specialised component consisting of covalent cross-links of proteins beneath the plasma membrane of terminally differentiated keratinocytes. Catalyses small proline-rich proteins (SPRR1 and SPRR2) and LOR cross-linking to form small interchain oligomers, which are further cross-linked by TGM1 onto the growing CE scaffold. In hair follicles, involved in cross-linking structural proteins to hardening the inner root sheath. Location: Cytoplasm (UniProt). Locus 20p13 (HGNC).
- Skin cancer: Open Targets association 0.54 with skin cancer (MONDO_0002898)
- Basal cell carcinoma: Open Targets association 0.53 with basal cell carcinoma (MONDO_0020804)
Notes
top- Written by scripts/fetch-cancer-genes.ts from CIViC, Open Targets, IntOGen, HGNC and UniProt; the function text is UniProt's, condensed and in UK spelling. Roles: none stated by the sources. Evidence tier "association-only" is the strongest of those signals.
- Prevalence not recorded: none of the sources gives a positivity rate.
Latest papers
topQuery for this target: (TITLE:"TGM3" OR ABSTRACT:"TGM3" OR TITLE:"transglutaminase 3" OR ABSTRACT:"transglutaminase 3" OR TITLE:"Protein-glutamine gamma-glutamyltransferase E" OR ABSTRACT:"Protein-glutamine gamma-glutamyltransferase E") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about TGM3, not a curated reading list.
Similar pages
not linked directly; found by shared links- TargetBNC2
Shares Basal cell carcinoma, Skin cancer (all types), Open Targets Platform.
- TargetCPVL
Shares Basal cell carcinoma, Skin cancer (all types), Open Targets Platform.
- TargetCTSS
Shares Basal cell carcinoma, Skin cancer (all types), Open Targets Platform.
- TargetKRT5
Shares Basal cell carcinoma, Skin cancer (all types), Open Targets Platform.
- TargetXPA
Shares Basal cell carcinoma, Skin cancer (all types), Open Targets Platform.
- TargetOCA2
Shares Basal cell carcinoma, Skin cancer (all types), Open Targets Platform.
- TargetSLC45A2
Shares Basal cell carcinoma, Skin cancer (all types), Open Targets Platform.
- TargetTYR
Shares Basal cell carcinoma, Skin cancer (all types), Open Targets Platform.